Insight Molecular Diagnostics Inc. Financing Cash Flow
Insight Molecular Diagnostics Inc. (IMDX) reported Financing Cash Flow of $24.13 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-10
- Insight Molecular Diagnostics Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$564.00K.
- Insight Molecular Diagnostics Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $24.70M, a 13.52% decline year-over-year.
- Insight Molecular Diagnostics Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$252.00K, a 102.33% decline year-over-year.
- Insight Molecular Diagnostics Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$120.00K.
- Insight Molecular Diagnostics Inc. net cash provided by (used in) financing activities for fiscal 2025 was $28.07M, a 37.41% increase from fiscal 2024.
- Insight Molecular Diagnostics Inc. net cash provided by (used in) financing activities for fiscal 2024 was $20.43M, a 67.64% increase from fiscal 2023.
- Insight Molecular Diagnostics Inc. net cash provided by (used in) financing activities for fiscal 2023 was $12.19M, a 65.97% decline from fiscal 2022.
- Insight Molecular Diagnostics Inc. net cash provided by (used in) financing activities for fiscal 2022 was $35.81M, a 54.31% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 6 month as first filed | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$564.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $24.13M 10-Q · filed 2026-08-10 | $23.88M derived: sum of 3 quarters · filed 2026-08-10 | $23.76M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2026-03-31 | $24.70M 10-Q · filed 2026-05-13 | $24.45M derived: sum of 2 quarters · filed 2026-05-13 | $24.33M derived: sum of 3 quarters · filed 2026-05-13 | $24.21M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-12-31 | -$252.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$372.00K derived: sum of 2 quarters · filed 2026-03-26 | -$486.00K derived: sum of 3 quarters · filed 2026-08-10 | $28.07M 10-K · filed 2026-03-26 | |
| 2025-09-30 | -$120.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | -$234.00K derived: sum of 2 quarters · filed 2026-08-10 | $28.32M 10-Q · filed 2025-11-10 | $39.16M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-06-30 | -$114.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $28.44M 10-Q · filed 2026-08-10 | $39.28M derived: sum of 3 quarters · filed 2026-08-10 | $39.03M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-03-31 | $28.56M 10-Q · filed 2026-05-13 | $39.40M derived: sum of 2 quarters · filed 2026-05-13 | $39.14M derived: sum of 3 quarters · filed 2026-05-13 | $48.99M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | $10.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $10.58M derived: sum of 2 quarters · filed 2026-03-26 | $20.43M derived: sum of 3 quarters · filed 2026-03-26 | $20.43M 10-K · filed 2026-03-26 | |
| 2024-09-30 | -$255.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $9.59M derived: sum of 2 quarters · filed 2025-11-10 | $9.59M 10-Q · filed 2025-11-10 | $9.56M derived: sum of 4 quarters · filed 2025-11-10 | |
| 2024-06-30 | $9.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $9.85M 10-Q · filed 2025-08-11 | $9.82M derived: sum of 3 quarters · filed 2025-08-11 | $9.79M derived: sum of 4 quarters · filed 2025-08-11 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-12 | -$30.00K derived: sum of 2 quarters · filed 2025-05-12 | -$60.00K derived: sum of 3 quarters · filed 2025-05-12 | $12.21M derived: sum of 4 quarters · filed 2025-05-12 | |
| 2023-12-31 | -$30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | -$60.00K derived: sum of 2 quarters · filed 2025-03-24 | $12.21M derived: sum of 3 quarters · filed 2025-03-24 | $12.19M 10-K · filed 2025-03-24 | |
| 2023-09-30 | -$30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $12.24M derived: sum of 2 quarters · filed 2024-11-12 | $12.22M 10-Q · filed 2024-11-12 | $12.12M derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | $12.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $12.25M 10-Q · filed 2024-08-08 | $12.15M derived: sum of 3 quarters · filed 2024-08-08 | $11.62M derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | -$28.00K 10-Q · filed 2024-05-15 | -$128.00K derived: sum of 2 quarters · filed 2024-05-15 | -$656.00K derived: sum of 3 quarters · filed 2024-05-15 | $36.13M derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | -$100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | -$628.00K derived: sum of 2 quarters · filed 2024-04-16 | $36.16M derived: sum of 3 quarters · filed 2024-04-16 | $35.81M 10-K · filed 2024-04-16 | |
| 2022-09-30 | -$528.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $36.26M derived: sum of 2 quarters · filed 2023-11-09 | $35.91M 10-Q · filed 2023-11-09 | $35.64M derived: sum of 4 quarters · filed 2023-11-09 | |
| 2022-06-30 | $36.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $36.43M 10-Q · filed 2023-08-10 | $36.48M 10-Q · filed 2022-08-12 | $36.16M derived: sum of 3 quarters · filed 2023-08-10 | $44.38M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | -$355.00K 10-Q · filed 2023-05-15 | -$624.00K derived: sum of 2 quarters · filed 2023-05-15 | $7.59M derived: sum of 3 quarters · filed 2023-05-15 | $8.14M derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | -$269.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-12 | $7.95M derived: sum of 2 quarters · filed 2023-04-12 | $8.49M derived: sum of 3 quarters · filed 2023-04-12 | $78.36M 10-K · filed 2023-04-12 | |
| 2021-09-30 | $8.21M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $8.76M derived: sum of 2 quarters · filed 2022-11-10 | $78.63M 10-Q · filed 2022-11-10 | $82.13M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $547.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $70.42M 10-Q · filed 2022-08-12 | $73.91M derived: sum of 3 quarters · filed 2022-08-12 | $73.94M derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | $69.87M 10-Q · filed 2022-05-12 | $73.36M derived: sum of 2 quarters · filed 2022-05-12 | $73.39M derived: sum of 3 quarters · filed 2022-05-12 | $85.11M derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $3.49M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $3.52M derived: sum of 2 quarters · filed 2022-03-11 | $15.23M derived: sum of 3 quarters · filed 2022-03-11 | $22.80M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $28.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $11.74M derived: sum of 2 quarters · filed 2021-11-09 | $19.31M 10-Q · filed 2021-11-09 | $30.16M derived: sum of 4 quarters · filed 2021-11-09 | |
| 2020-06-30 | $11.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $19.28M 10-Q · filed 2021-08-11 | $30.13M derived: sum of 3 quarters · filed 2021-08-11 | $29.83M derived: sum of 4 quarters · filed 2021-08-11 | |
| 2020-03-31 | $7.57M 10-Q · filed 2021-05-17 | $18.41M derived: sum of 2 quarters · filed 2021-05-17 | $18.12M derived: sum of 3 quarters · filed 2021-05-17 | $17.54M derived: sum of 4 quarters · filed 2021-05-17 | |
| 2019-12-31 | $10.85M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19 | $10.55M derived: sum of 2 quarters · filed 2021-03-19 | $9.97M derived: sum of 3 quarters · filed 2021-03-19 | $47.87M 10-K · filed 2021-03-19 | |
| 2019-09-30 | -$296.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$876.00K derived: sum of 2 quarters · filed 2020-11-12 | $37.02M 10-Q · filed 2020-11-12 | $36.69M derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | -$580.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $37.31M 10-Q · filed 2020-07-29 | $36.98M derived: sum of 3 quarters · filed 2020-07-29 | $40.00M derived: sum of 4 quarters · filed 2020-07-29 | |
| 2019-03-31 | $37.89M 10-Q · filed 2020-05-12 | $37.56M derived: sum of 2 quarters · filed 2020-05-12 | $40.58M derived: sum of 3 quarters · filed 2020-05-12 | $42.24M derived: sum of 4 quarters · filed 2020-05-12 | |
| 2018-12-31 | -$331.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | $2.69M derived: sum of 2 quarters · filed 2020-03-26 | $4.34M derived: sum of 3 quarters · filed 2020-03-26 | $12.11M 10-K · filed 2020-03-26 | |
| 2018-09-30 | $3.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $4.67M derived: sum of 2 quarters · filed 2019-11-14 | $12.45M 10-Q · filed 2019-11-14 | $12.37M derived: sum of 4 quarters · filed 2019-11-14 | |
| 2018-06-30 | $1.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $9.43M 10-Q · filed 2019-08-14 | $9.35M derived: sum of 3 quarters · filed 2019-08-14 | $15.23M derived: sum of 4 quarters · filed 2019-08-14 | |
| 2018-03-31 | $7.77M 10-Q · filed 2019-05-14 | $7.70M derived: sum of 2 quarters · filed 2019-05-14 | $13.58M derived: sum of 3 quarters · filed 2019-05-14 | $13.76M derived: sum of 4 quarters · filed 2019-05-14 | |
| 2017-12-31 | -$74.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $5.81M derived: sum of 2 quarters · filed 2019-04-01 | $5.99M derived: sum of 3 quarters · filed 2019-04-01 | $9.97M 10-K · filed 2019-04-01 | |
| 2017-09-30 | $5.88M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $6.06M derived: sum of 2 quarters · filed 2018-11-13 | $10.04M 10-Q · filed 2018-11-13 | $10.16M derived: sum of 4 quarters · filed 2018-11-13 | |
| 2017-06-30 | $180.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $4.16M 10-Q · filed 2018-08-14 | $4.28M derived: sum of 3 quarters · filed 2018-08-14 | $14.00M derived: sum of 4 quarters · filed 2018-08-14 | |
| 2017-03-31 | $3.98M 10-Q · filed 2018-05-15 | $4.10M derived: sum of 2 quarters · filed 2018-05-15 | $13.82M derived: sum of 3 quarters · filed 2018-05-15 | ||
| 2016-12-31 | $122.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $9.84M derived: sum of 2 quarters · filed 2018-04-02 | $9.88M 10-K · filed 2018-04-02 | ||
| 2016-09-30 | $9.72M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $9.76M 10-Q · filed 2017-11-14 | |||
| 2016-06-30 | $42.00K 10-Q · filed 2017-08-14 | ||||
| 2015-12-31 | $11.65M 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |